Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors
SAN DIEGO, April 16, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Johanna Mercier to…
Börse:
95,821$
1,02%
Echtzeit-Aktienkurs Neurocrine Biosciences Inc.
Bid:
95,154$
Ask:
96,488$
Nachrichtenticker der Neurocrine Biosciences Inc. Aktie
Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors
SAN DIEGO, April 16, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Johanna Mercier to its Board of Directors. Ms. Mercier is the Chief Commercial Officer of Gilead Sciences, with responsibility fo...
Den vollständigen Artikel können Sie lesen unter: https://www.prnewswire.com:443/news-releases/neurocrine-biosciences-announces-appointment-of-johanna-mercier-to-board-of-directors-301270422.html.
Den vollständigen Artikel können Sie lesen unter: https://www.prnewswire.com:443/news-releases/neurocrine-biosciences-announces-appointment-of-johanna-mercier-to-board-of-directors-301270422.html.